Absci Corp at JPMorgan Healthcare Conference Transcript
Good morning, everybody. Welcome to the 42nd Annual J.P. Morgan Healthcare Conference. My name is Dan Delfico. I'm one of the associates on the healthcare banking team here. This morning, it's my pleasure to introduce you to the Absci team. With us today, we have Sean McClain, Founder and CEO.
(Conference Instructions)
So with that, I'm going to turn it over to Sean.
Great. Thank you, Dan and J.P. Morgan, for hosting us here. As Dan said, I'm Sean McClain, the Founder and CEO of Absci. We're a data-first generative AI drug creation company. And you may recall from last J.P. Morgan, we announced some really exciting breakthroughs in generative AI for biologic design.
Being able to design an antibody from scratch with a generative AI model, being able to feed in a target of interest, and then being able to have a binder to that target.
Now, that was a big technical feat from an AI perspective. And we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |